Independent 503a compounding pharmacy — pharmacist-led, not investor-driven
Partnerships
Voshell’s Partners With the Full Healthcare Ecosystem
Meeting patients everywhere they are: Voshell’s partnership ecosystem spans Telehealth, Hospitals, Corporate Wellness, Assisted Living, Concierge Medicine & Specialty Care.
Telehealth platforms need a 503a compounding partner that can match clinical depth with operational reliability. Voshell’s has been Baltimore’s compounding pharmacy since 1927, and today we work with telehealth founders, pharmacy operations leads, and chief medical officers across the country to prepare patient-specific compounded prescriptions with the consistency, compliance posture, and clinical fluency platform patients deserve.
What We Bring to Telehealth Partnerships
Five-state licensure: Maryland, Delaware, Pennsylvania, Virginia, and Washington DC
LegitScript verified, HIPAA-compliant intake and fulfillment infrastructure
Compliance-first framing on peptides, hormones, and FDA enforcement-sensitive compounds
Pharmacist team fluent in metabolic, peptide, hormone, NAD, LDN, and detox protocols
Direct prescriber liaison line — your clinical team and ours, in conversation
Where We Partner
Metabolic Health Platforms
For platforms supporting members with metabolic health — Function Health, Levels, NutriSense, and similar — Voshell’s provides compounded thyroid support, BHRT, and TRT formulations when prescriber-indicated, prepared to your prescribers’ exact specifications.
Peptide Therapy Platforms
For peptide-focused platforms, Voshell’s pharmacy compounds the peptide formulations currently authorized for 503A compounding: sermorelin, ipamorelin, CJC-1295, and PT-141 in nasal formulation. BPC-157 and TB-500 are pending FDA PCAC review; we will update our formulary immediately upon authorization and notify partner platforms directly.
Hormone Therapy Platforms
For BHRT and TRT-focused platforms, Voshell’s pharmacy compounds estradiol, progesterone, testosterone, thyroid, DHEA, and pregnenolone in single-agent and combination formulations across cream, sublingual, and injectable routes, prepared to your prescribers’ exact specifications.
How Partnership Works
01
Discovery call with our pharmacist team — understand your platform, your patient population, your clinical workflow, and where Voshell’s can fill the gap.
02
Compliance and capacity review — confirm licensure, formulary alignment, turnaround capability, and HIPAA-compliant integration.
03
Pilot engagement — start with a defined patient cohort or service line before broader rollout.
04
Ongoing partnership — direct pharmacist liaison, dedicated operations contact, quarterly business reviews.
Compliance
Compliance Posture
Voshell’s takes a compliance-first approach to every partnership. We don’t operate in gray areas — every compound meets rigorous QA and QC standards, we vet the prescribers we work with, and we vet our vendors. That same due diligence applies to every enterprise partnership before we fulfill a single prescription. For platforms supporting metabolic health, Voshell’s compounds BHRT, TRT, and authorized peptide formulations under prescriber leadership.
Build a Smarter Telehealth Pharmacy Partnership
Partner with a pharmacist-led compounding pharmacy built for long-term operational trust, clinical sophistication, and scalable telehealth fulfillment.